Onderneming Obio Technology (Shanghai) Corp., Ltd.
Aandelen
688238
CNE1000059N9
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,17 CNY | +1,98% | +12,39% | -31,37% |
Vakgebied
Aantal werknemers: 741
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Gene Therapy Contract Development and Manufacturing Organization
52,2
%
| 217 | 74,4 % | 107 | 52,2 % | -50,64% |
Gene Therapy Contract Research Organization
38,8
%
| 66 | 22,6 % | 79 | 38,8 % | +20,56% |
Biological Agents, Reagents and Others
9,0
%
| 7 | 2,3 % | 18 | 9,0 % | +176,90% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
China
92,2
%
| 278 | 95,3 % | 189 | 92,2 % | -32,01% |
Other Areas
7,7
%
| 13 | 4,3 % | 16 | 7,7 % | +24,99% |
Overseas
0,2
%
| 1 | 0,4 % | 0 | 0,2 % | -70,90% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Guo Dong Jia
CEO | Chief Executive Officer | 43 | 01-02-17 |
Rui Dong Pan
CHM | Chairman | 56 | 01-03-13 |
Lu Yuan Xu
DFI | Director of Finance/CFO | 54 | 01-10-16 |
Zhao Rui Song
BRD | Director/Board Member | 49 | 01-07-21 |
Jun Yi Pan
BRD | Director/Board Member | 30 | 01-04-17 |
Fu Jie Wang
BRD | Director/Board Member | 49 | 01-02-14 |
Shan Yin
BRD | Director/Board Member | 42 | 01-06-13 |
Wen Zhao
IRC | Investor Relations Contact | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shan Yin
BRD | Director/Board Member | 42 | 01-06-13 |
Gang Wang
BRD | Director/Board Member | 67 | 29-12-20 |
Rui Dong Pan
CHM | Chairman | 56 | 01-03-13 |
Guo Dong Jia
CEO | Chief Executive Officer | 43 | 01-02-17 |
Zheng Qi Song
BRD | Director/Board Member | 43 | 29-12-20 |
Li Ning Gan
BRD | Director/Board Member | 46 | 29-12-20 |
Fu Jie Wang
BRD | Director/Board Member | 49 | 01-02-14 |
Ke Jia Yuan
BRD | Director/Board Member | 40 | 10-10-20 |
Si Jie Song
BRD | Director/Board Member | 29 | 01-11-18 |
Jun Yi Pan
BRD | Director/Board Member | 30 | 01-04-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 647 433 100 | 435 929 937 ( 67,33 %) | 0 | 67,33 % |
Bedrijfsgegevens
Obio Technology Shanghai Corp. Ltd.
Building 19, Lane 908 Ziping Road
201318, Shanghai
+
http://www.obiosh.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-31,37% | 552 mln. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
+8,08% | 167 mld. | |
-3,40% | 157 mld. |
- Beurs
- Aandelen
- Koers 688238
- Onderneming Obio Technology (Shanghai) Corp., Ltd.